{"mainPropery":{"diseaseId":6332,"diseaseName":"Encephalitis lethargica","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6332/encephalitis-lethargica","synonyms":["Von Economo’s disease","Von Economo encephalitis"],"synonyms-with-source":[{"name":"Von Economo’s disease"},{"name":"Von Economo encephalitis","source":"Orphanet"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"83600"},{"identifierType":"UMLS","identifierId":"C0014040"}]},"diseaseCategories":[{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=%22encephalitis+lethargica%22%5BAll+Fields%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Encephalitis lethargica. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/Encephalitis-Lethargica-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=83600' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:5225' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1204,"questionText":"What is encephalitis lethargica?","answerText":"<strong>Encephalitis lethargica</strong>&nbsp;(EL) is a disease characterized by high fever, headache, double vision, delayed physical and mental response, extreme tiredness&nbsp;(<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003088.htm\" target=\"_blank\">lethargy</a>), and sometimes <a href=\"http://www.ninds.nih.gov/disorders/coma/coma.htm\" target=\"_blank\">coma</a>. Patients may also experience abnormal eye movements, upper body weakness, muscle pain, <a href=\"https://www.nlm.nih.gov/medlineplus/tremor.html\" target=\"_blank\">tremors</a>, neck rigidity, and behavioral changes including <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001553.htm\" target=\"_blank\">psychosis</a>. A worldwide epidemic of EL occurred from 1917 to 1928 with more than one million reported cases.[718][11667] Although occasional cases are reported with similar symptoms, EL epidemics have not recurred.[718] The cause of&nbsp;this condition&nbsp;is unknown, but a viral origin is suspected.[11667] Treatment depends on a person's symptoms. <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601068.html\" target=\"_blank\">Levodopa</a> and other antiparkinson drugs may be effective in alleviating some symptoms.[718]","dateModified":"2016-06-07T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":22520,"abbreviatedInquiry":"When I was about 8-years-old, I was hospitalized due to encephalitis lethargica. I was extremely ill and it took me a long time to recover. Last May, I was diagnosed with a benign meningioma.&nbsp;Could my childhood illness&nbsp;be related to the development of my tumor?&nbsp;Are there any documented cases of meningioma in other&nbsp;survivors of encephalitis lethargica?","caseQuestions":[{"questionId":1204,"questionText":"What is encephalitis lethargica?","answerText":"<strong>Encephalitis lethargica</strong>&nbsp;(EL) is a disease characterized by high fever, headache, double vision, delayed physical and mental response, extreme tiredness&nbsp;(<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003088.htm\" target=\"_blank\">lethargy</a>), and sometimes <a href=\"http://www.ninds.nih.gov/disorders/coma/coma.htm\" target=\"_blank\">coma</a>. Patients may also experience abnormal eye movements, upper body weakness, muscle pain, <a href=\"https://www.nlm.nih.gov/medlineplus/tremor.html\" target=\"_blank\">tremors</a>, neck rigidity, and behavioral changes including <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001553.htm\" target=\"_blank\">psychosis</a>. A worldwide epidemic of EL occurred from 1917 to 1928 with more than one million reported cases.[718][11667] Although occasional cases are reported with similar symptoms, EL epidemics have not recurred.[718] The cause of&nbsp;this condition&nbsp;is unknown, but a viral origin is suspected.[11667] Treatment depends on a person's symptoms. <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601068.html\" target=\"_blank\">Levodopa</a> and other antiparkinson drugs may be effective in alleviating some symptoms.[718]","dateModified":"2016-06-07T00:00:00","references":[{"referenceId":718,"authors":"","articleTitle":"NINDS Encephalitis Lethargica Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke Website","date":"February 12, 2007","volume":"","pages":"","url":"http://www.ninds.nih.gov/disorders/encephalitis_lethargica/encephalitis_lethargica.htm","dateAccessed":"2016-06-07T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11667,"authors":"Dennis Tappea, David E. Alquezar-Planas","articleTitle":"Medical and molecular perspectives into a forgotten epidemic: Encephalitis lethargica, viruses, and high-throughput sequencing","bookWebsiteJournalTitle":"Journal of Clinical Virology","date":"October 2014","volume":"61(2)","pages":"189-195","url":"https://www.ncbi.nlm.nih.gov/pubmed/25129855","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1205,"questionText":"Are there any documented cases of meningioma in survivors of encephalitis lethargica?","answerText":"After an extensive review of the medical literature, we were not able to find a report of <a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=45783\" target=\"_blank\">meningioma</a> occurring in a survivor of encephalitis lethargica (EL). As the majority of cases occurred between 1917 and 1928, there may be a lack of data in the medical literature reporting symptoms of survivors of EL. If you are interested in searching for journal articles on encephalitis lethargica, you can use the online <a href=\"http://www.pubmed.gov\" target=\"_blank\">PubMed</a> database. We have included a sample search&nbsp;on our <a href=\"http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&amp;DiseaseID=6332&amp;expand=MoreInformation#MoreInformation\" target=\"_blank\">resource page for encephalitis lethargica</a>.","dateModified":"2016-06-07T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":9387,"phenoTypeName":"Encephalopathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11439,"phenoTypeName":"Sleep disturbance","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15315,"phenoTypeName":"Abnormal involuntary eye movements","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4355,"phenoTypeName":"Autoimmunity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9373,"phenoTypeName":"Bilateral basal ganglia lesions","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10125,"phenoTypeName":"Diplopia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":149,"phenoTypeName":"Dyskinesia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11409,"phenoTypeName":"Headache","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4825,"phenoTypeName":"Increased circulating antibody level","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4328,"phenoTypeName":"Increased CSF protein","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8721,"phenoTypeName":"Lethargy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8727,"phenoTypeName":"Mental deterioration","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9388,"phenoTypeName":"Parkinsonism","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7728,"phenoTypeName":"Pharyngitis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9215,"phenoTypeName":"Recurrent viral infections","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9423,"phenoTypeName":"Tremor","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13597,"phenoTypeName":"Upper limb muscle weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13777,"phenoTypeName":"Bowel incontinence","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8991,"phenoTypeName":"Bradycardia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8702,"phenoTypeName":"Coma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4294,"phenoTypeName":"Hyperventilation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":461,"phenoTypeName":"Limb pain","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9198,"phenoTypeName":"Photophobia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6006,"phenoTypeName":"Psychosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11237,"phenoTypeName":"Stiff neck","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6356,"phenoTypeName":"Urinary incontinence","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Encephalitis_lethargica"}